metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
DBCOND0146851Neoplasms
metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma is the indication for 1 drug in DrugBank. It is covered by 2 curated, structured indications.
- Classified under
- Indicated drugs
What you can answer from here — as of October 22, 2026
1Indicated drugWith each drug's targets and mechanismListed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not proseSign in
Which approved drugs for metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma share a target, and which companies have late-stage candidates against it?
Create a free account or log in to explore the full data card.
Create Account